- Home
- CDNA vs OLPX Comparison
CDNA vs OLPX Comparison
Compare CDNA & OLPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- OLPX
- Stock Information
- Founded
- CDNA 1998
- OLPX 2014
- Country
- CDNA United States
- OLPX United States
- Employees
- CDNA N/A
- OLPX N/A
- Industry
- CDNA Medical Specialities
- OLPX Package Goods/Cosmetics
- Sector
- CDNA Health Care
- OLPX Consumer Discretionary
- Exchange
- CDNA Nasdaq
- OLPX Nasdaq
- Market Cap
- CDNA 712.2M
- OLPX 733.8M
- IPO Year
- CDNA 2014
- OLPX 2021
- Fundamental
- Price
- CDNA $14.50
- OLPX $1.05
- Analyst Decision
- CDNA Buy
- OLPX Buy
- Analyst Count
- CDNA 8
- OLPX 4
- Target Price
- CDNA $26.86
- OLPX $1.88
- AVG Volume (30 Days)
- CDNA 951.2K
- OLPX 919.7K
- Earning Date
- CDNA 11-04-2025
- OLPX 11-06-2025
- Dividend Yield
- CDNA N/A
- OLPX N/A
- EPS Growth
- CDNA N/A
- OLPX N/A
- EPS
- CDNA 1.00
- OLPX N/A
- Revenue
- CDNA $340,826,000.00
- OLPX $423,083,000.00
- Revenue This Year
- CDNA $12.73
- OLPX $1.81
- Revenue Next Year
- CDNA $11.90
- OLPX $2.86
- P/E Ratio
- CDNA $14.81
- OLPX N/A
- Revenue Growth
- CDNA 14.72
- OLPX N/A
- 52 Week Low
- CDNA $10.96
- OLPX $1.01
- 52 Week High
- CDNA $26.37
- OLPX $2.28
- Technical
- Relative Strength Index (RSI)
- CDNA 48.78
- OLPX 30.05
- Support Level
- CDNA $14.23
- OLPX $1.01
- Resistance Level
- CDNA $15.29
- OLPX $1.15
- Average True Range (ATR)
- CDNA 0.63
- OLPX 0.05
- MACD
- CDNA -0.05
- OLPX -0.01
- Stochastic Oscillator
- CDNA 31.72
- OLPX 12.00
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About OLPX Olaplex Holdings Inc.
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.